NEW YORK, Feb 13 – Structural proteomics company GeneFormatics said Tuesday it had hired Daniel Chambers as its vice president of intellectual property, a move designed to protect the company’s patent position.
San Diego-based GeneFormatics also announced that it has retained Michael Liebman as a strategic adviser for business development.
GeneFormatics, which initially focused on developing an in silico approach to protein structure, recently began expanding its proteomics capabilities. In January GeneFormatics acquired Structure Function Genomics, a Princeton, NJ-based developer of tools to speed up nuclear magnetic resonance spectroscopy. At the time, the company also signed a commercial license deal with Rutgers University for some NMR spectroscopy technology developed by Gaetano Montelione’s lab at Rutgers.
GeneFormatics is now looking to build its X-ray crystallography capabilities either through acquisitions or partnerships.
Prior to joining GeneFormatics, Chambers was in private practice at Brobeck, Phleger & Harrison LLP, Lyon & Lyon, and Wilson Sonsini Goodrich & Rosati. He has also worked in the legal departments at Amgen and Viagene. Liebman is director of computational biology and investigator for the Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine.
GeneFormatics, which has raised $15 million in venture capital, provides services to companies such as Schering-Plough, Bristol-Myers Squibb, and AstraZeneca.